Event Details
XBiotech Inc at the 26th EADV Congress
Sep 14, 2017 at 2:00 PM CEST
Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa will be presented.
Location
Geneva, Switzerland
